Related Experiment Video
Updated: Mar 22, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a
Giulia Maurizi1, Domenico Mattiucci1, Marianna Mariani1
1Clinica di Ematologia, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy.
No abstract available in PubMed .
More Related Videos
11:53An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
Published on: June 1, 2018
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Related Concept Videos
Mesenchymal Stem Cells
Satellite Stem Cells and Muscular Dystrophy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Forced Transdifferentiation
Artificial...